Mertz Amsilli Pérez Tanoira F. Adesanya

106 SCIENTIFIC SESSIONS September 9-12 | K-942 Valve Surgery in Infective Endocarditis: Determinants of In-Hospital Prognosis M. Martinez-Selles 1 , A. Arnaiz 2 , P. Muñoz 1 , J. Ruiz 3 , M. Moreno 4 , J. Reguera 5 , J. Galvez 6 , J. Portu 7 , J. Oteo 8 , J. dela Torre 9 , E. Bouza- Prof 1 , GAMES; 1 H G.U. Gregorio Marañón. Univ. of Madrid, Madrid, Spain, 2 Hosp. Valdecilla, Santander, Spain, 3 Hosp. V Victoria, Málaga, Spain, 4 Hosp. La Paz, Madrid, Spain, 5 Hosp. Carlos Haya, Malaga, Spain, 6 Hosp. V Macarena, Seville, Spain, 7 Hosp. Txagorritxu, Barakaldo, Spain, 8 Hosp. San Pedro, La Rioja, Spain, 9 Hosp. Costa del Sol, Marbella, Spain. K-943 Short-Term and Long-Term Mortality Risk Factors in a Prospective Cohort of 1000 Consecutive Infective Endocarditis in Spain GAMES

P. Muñoz

1 , M. Fariñas 2 , A. Alarcón 3 , L. Castelo 4 , J. Miró 5 , M. Montejo 6 , E. Navas 7 , R. Ivanova 8 , J. Paño 9 , A. Moreno 10 , C. Hidalgo-Tenorio 11 , M. Goenaga 12 , A. Plata 13 , M. Rodríguez 1 , E. Bouza 1 , GAMES; 1 Hosp. G.U. Gregorio Marañón. Univ. of Madrid, Madrid, Spain, 2 Hosp. Valdecilla, Santander, Spain, 3 Hosp.V del Rocío, Sevilla, Spain, 4 Hosp. Juan Canalejo, Coruña, Spain, 5 Hosp. Clinic, Barcelona, Spain, 6 Hosp. Cruces, Bilbao, Spain, 7 Hosp. Ramón y Cajal, Madrid, Spain, 8 Hosp. V Victoria, Málaga, Spain, 9 Hosp. La Paz, Madrid, Spain, 10 Hosp. Central Asturias, Oviedo, Spain, 11 H V Nieves, Granada, Spain, 12 Hosp. Donosti, San Sebastián, Spain, 13 Hosp. Carlos Haya, Málaga, Spain. K-944 Efficacy of Daptomycin in the Treatment of Enterococcal Endocarditis: A 5-Year Perspective I. Ceron, P. Muñoz, M. Marin, M. Rodríguez-Créixems, B. Pinilla, A. Segado, J. Roda, H. Rodríguez, M. Valerio, A. Fernandez-Cruz, A. Burillo, E. Bouza- ID prof, GAME; Hosp. G.U. Gregorio Marañón, Univ. of Ma- drid, Madrid, Spain. K-945 Changes in the Antibiotic Treatment of Enterococcus faecalis Infective Endocarditis EF-IE in the Last 15 Years J. M. Pericas, C. Cervera, A. del Río, C. García-De-La-Maria, Ph , A. Moreno, X. Castañeda, M. Almela, C. Falces, S. Ninot, Y. Armero, C. A. Mestres, D. Soy, J. M. Gatell, F. Marco, J. M. Miró, Hospital Clinic Endo- carditis Study Group; Hosp. Clinic - IDIBAPS, Barcelona, Spain. K-946 Evaluation of Population Analysis Profile Susceptibility PAP as a Predictor of Patient Outcomes with Methicillin-Resistant Staphylococcus aureus MRSA Infective Endocarditis IE A. M. Casapao, S. Patel , R. Kullar, S. L. Davis, M. J. Rybak; Wayne State Univ., Anti-Infective Res. Lab., Detroit, MI. ------------------------------------------------------------------------ 107 K Poster Session Fungal Infections Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-947 Candidaemia in Malaysia: Surprising Results from a National Study

Q. A. Nguyen

1,2 , D. J. E. Marriott 1 , Malaysian Candidaemia Study MaCaS Group; 1 St. Vincent’s Hosp. Sydney, Sydney, Australia, 2 Garvan Inst. of Med. Res., Sydney, Australia. K-948 Predictors of Poor Outcome in Candidemia: A Population- Based Surveillance for Candidemia in Spain

M. Puig

1 , B. Padilla 2 , J. Garnacho 3 , R. Zaragoza 4 , P. Muñoz 2 , J. Aguado 5 , M. Montejo 6 , B. Almirante 1 , CANDIPOP Project, GEIH-GEMI- COMED SEIMC and REIPI.; 1 Hosp. Vall d´Hebron, Barcelona, Spain, 2 Hosp. Gregorio Marañón, Madrid, Spain, 3 Hosp. Virgen del Rocio, Sevilla, Spain, 4 Hosp. Univ. Dr. Peset, Valencia, Spain, 5 Hosp. 12 de Octubre, Ma- drid, Spain, 6 Hosp. Cruces, Bilbao, Spain. K-949 Predictors of Candida sp. as a Causative Agent of Catheter- Related Bloodstream Infections M. Nagao, G. Hotta, M. Yamamoto, Y. Matsumura, A. Matsushima, Y. Ito, S. Takakura, S. Ichiyama; Kyoto Univ. Hosp., Kyoto, Japan. K-950 Candida Bloodstream Infections BSI in the Intensive Care Unit ICU Adult Patients

M. Puig

1 , J. Garnacho 2 , R. Zaragoza 3 , J. Pemán 4 , M. Valerio 5 , E. Martin- Mazuelos 6 , B. Almirante 1 , CANDIPOP Project, GEIH-GEMICOMED and REIPI; 1 Hosp. Vall d´Hebron, Barcelona, Spain, 2 Hosp. Virgen del Rocio, sevilla, Spain, 3 Hosp. Univ. Dr. Peset, Valencia, Spain, 4 Hosp. La Fe, Valencia, Spain, 5 Hosp. gregorio Marañon, Madrid, Spain, 6 Hosp. de Valme, Sevilla, Spain. K-951 Outcome and Risk Factors for Mortality in Critically Ill Patients with Invasive Pulmonary Aspergillosis

S. Blot

1 , J. Rello 2 , G. Dimopoulos 3 , K. Vandewoude 1 , D. Vogelaers 1 , and the AspICU Study Investigators; 1 Ghent Univ., Gent, Belgium, 2 Vall d’hebron Univ. Hosp., Barcelona, Spain, 3 Athens Attikon Univ. Hosp., Athens, Greece. ------------------------------------------------------------------------ 108 K Poster Session Influenza Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-952 Hospital-Acquired Influenza in an Australian Sentinel Sur- veillance System

N. Macesic

1 , T. Kotsimbos 1,2 , P. M. Kelly 3 , A. C. Cheng 1,2 , FluCAN In- vestigators; 1 Alfred Hlth., Melbourne, Australia, 2 Monash Univ., Melbourne, Australia, 3 Australian Natl. Univ., Canberra, Australia. K-953 Vaccination against Influenza at a European Pediatric Cancer Center: Immunization Rates and Attitudes among Staff Members S. Jocham, A. Wiener, J. Groenefeld, A. Loecken, J. Kuehn, A. H. Groll; Univ. Hosp., Muenster, Germany. K-954 Nosocomial Outbreak of Seasonal Influenza in a Geriatric Hospital L. Pagani 1 , V. Sauvan 1 , A. Iten 1 , L. Kaiser 2 , S. Harbarth 1 , D. Pittet 1 ; 1 Infection Control Program, Geneva, Switzerland, 2 Lab. of Virology, Geneva, Switzerland. K-955 Risk For Death From Seasonal and Pandemic Influenza: A Systematic Review

D. Mertz

1 , T. Kim 1 , J. Johnstone 1 , P. Lam 2 , M. Science 1 , S. P. Kuster 3 , S. A. Fadel 2 , D. Tran 2 , N. Bathnagar 1 , M. Loeb 1 ; 1 McMaster Univ., Hamilton, Canada, 2 Univ. of Toronto, Toronto, Canada, 3 Univ. Hosp. Zurich, Zurich, Switzerland. 107 MONDAY SCIENTIFIC SESSIONS Final Program K-956 Epidemic of Seasonal Influenza in an Internal Medicine Service A. Iten, S. Manuel, L. Pagani, Y. Thomas, V. Camus, L. Kaiser, A. Perrier, D. Pittet; HUG, Geneva, Switzerland. ------------------------------------------------------------------------ 109 L1 Poster Session An Update on Tuberculosis Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: L1-957 Use of Fluoroquinolons in Tuberculosis Regimen in Northern Paris and Northern France, between 2004 and 2011

M. Amsilli

1 , A. Blanc 2 , H. Ferrand 1 , E. Senneville 2 , E. Papy 1 , A. Vachée 3 , R. Ruimy 1 , E. Bouvet 1 , X. Lemaire 4 , Y. Yazdanpanah 1,2 ; 1 Hosp. Bichat, Paris, France, 2 Hosp. Gustave Dron, Tourcoing, France, 3 Ctr. Hosp., Roubaix, France, 4 Ctr. Hosp., Douai, France. L1-958 Tolerance and Safety of Intravenous Streptomycin Therapy in Patients with Tuberculosis

R. Pérez Tanoira

1 , R. Fernández-Roblas 1 , F. Sánchez-Patán 2 , A. Jiménez Girón 2 , J. Esteban Moreno 1 , M. Fernández Guerrero 1 ; 1 Fundación Jiménez Díaz, Madrid, Spain, 2 Inst. of Food Sci. Res., Madrid, Spain. L1-959 Predictors of Non-Adherence to a Pharmacist-Managed Treatment Program for Latent Tuberculosis Infection LTBI Among Homeless Population

A. F. Adesanya

1 , A. Le 2 , L. Nelson 3 , J. Hirsch 2 , S. Lorentz 2 ; 1 Comprehen- sive Pharm Services, Memphis, TN, 2 Univ. of California, San Diego, La Jolla, CA, 3 Univ. of Louisville Hosp., Louisville, KY. ------------------------------------------------------------------------ 110 L1 Poster Session Zoonotic Infections Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: L1-960 Imaging Techniques Radyograph, Scintigraphy and Mag- netic Rezonance Imaging in Brucellar Sacroiliitis Can be Used as a Criteria for a Follow-Up in the Termination of Treatment A. Bilgeturk, H. C. Gul, A. Karakas, G. Mert, C. Artuk, C. P. Eyigun; Gulhane Military Med. Sch., Ankara, Turkey. L1-961 Brucella Melitensis BM Bacteremia in Adult Hospitalized Patients in Southern Israel Y. Glick, E. Levin, L. Saidel-Odes, F. Schlaeffer, K. Riesenberg; Soroka Univ. Med. Ctr. SUMC and Faculty of Hlth. Sci., Ben Gurion Univ. of the Negev, Beer Sheva, Israel. L1-962 Timing of Antibiotic and Surgical Treatment of Q-Fever Endocarditis Y. Maor, A. Kogan, B. Orlov, H. Cohen, L. Sternik, A. Malachy, E. Raanani, G. Rahav; Sheba Med. Ctr., Tel Hashomer, Israel. L1-963 Chronic Q Fever: Clinical Data and Outcome F. Laterza 1 , A. Elsendoorn 1 , S. Sunder 2 , G. Beraud 1 , G. Le Moal 1 , S. Edouard 3 , A. Riche 4 , M. Texereau 5 , D. Boutoille 6 , C. Godet 1 , F. Roblot 1 , GERICCO; 1 Univ. Hosp., Poitiers, France, 2 Univ. Hosp., Tours, France, 3 Natl. Reference Ctr., Univ. Aix-Marseille, Marseille, France, 4 Gen. Hosp., Angoulême, France, 5 General Hosp., Niort, France, 6 Univ. Hosp., Nantes, France. L1-964 Phylogeography of Francisella tularensis Subspecies Holarc- tica from the Country of Turkey

Y. Ozsurekciship